Teva Pharmaceutical Industries ADR
(TEVA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,177,000 | 1,975,000 | 1,782,000 | 963,000 | 988,000 |
| Receivables | 4,581,000 | 5,676,000 | 5,822,000 | 7,128,000 | 7,523,000 |
| Inventories | 4,403,000 | 4,422,000 | 4,731,000 | 4,924,000 | 4,954,000 |
| Other current assets | 899,000 | 521,000 | 560,000 | 1,267,000 | 2,134,000 |
| TOTAL | $13,005,000 | $13,464,000 | $13,794,000 | $15,382,000 | $17,228,000 |
| Non-Current Assets | |||||
| PPE Net | 6,296,000 | 6,436,000 | 6,868,000 | 7,673,000 | 8,073,000 |
| Intangibles | 29,547,000 | 36,078,000 | 38,922,000 | 46,054,000 | 65,896,000 |
| Other Non-Current Assets | 1,792,000 | 1,491,000 | 1,099,000 | 1,506,000 | 1,860,000 |
| TOTAL | $37,635,000 | $44,005,000 | $46,889,000 | $55,233,000 | $75,829,000 |
| Total Assets | $50,640,000 | $57,470,000 | $60,683,000 | $70,615,000 | $93,057,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 3,188,000 | 2,345,000 | 2,216,000 | 3,646,000 | 3,276,000 |
| Accounts payable and accrued liabilities | 1,756,000 | 1,718,000 | 1,853,000 | 2,069,000 | 2,157,000 |
| Accrued Expenses | 2,465,000 | 2,562,000 | 2,738,000 | 3,563,000 | 4,264,000 |
| Other current liabilities | 5,757,000 | 7,048,000 | 7,515,000 | 8,605,000 | 8,675,000 |
| TOTAL | $13,164,000 | $13,674,000 | $14,322,000 | $17,921,000 | $18,488,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 22,731,000 | 24,562,000 | 26,700,000 | 28,829,000 | 32,524,000 |
| Other Non-Current Liabilities | 2,828,000 | 3,077,000 | 2,049,000 | 2,027,000 | 1,657,000 |
| TOTAL | $26,414,000 | $28,733,000 | $30,567,000 | $33,949,000 | $39,576,000 |
| Total Liabilities | $39,579,000 | $42,407,000 | $44,889,000 | $51,870,000 | $58,064,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,096,512 | 1,092,189 | 1,089,389 | N/A | N/A |
| Common Shares | 57,000 | 56,000 | 56,000 | 54,000 | 54,000 |
| Retained earnings | -10,946,000 | -6,956,000 | -5,958,000 | -3,803,000 | 13,607,000 |
| Other shareholders' equity | -1,365,000 | -1,221,000 | -1,372,000 | -467,000 | -1,503,000 |
| TOTAL | $11,061,000 | $15,063,000 | $15,794,000 | $18,745,000 | $34,993,000 |
| Total Liabilities And Equity | $50,640,000 | $57,470,000 | $60,683,000 | $70,615,000 | $93,057,000 |